Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  LifeVantage Corporation    LFVN

LIFEVANTAGE CORPORATION

(LFVN)
  Report
SummaryQuotesChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news

LifeVantage to Announce First Quarter Fiscal Year 2021 Results on November 3, 2020

10/20/2020 | 08:00am EST

SALT LAKE CITY, Oct. 20, 2020 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) announced today that it will release financial results for its first quarter ended September 30, 2020, after the stock market closes on Tuesday, November 3, 2020. The Company will hold a conference call for investors at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) that same day.

Investors interested in participating in the live call can dial (877) 705-6003 from the U.S. or international callers can dial (201) 493-6725. A telephone replay will be available approximately two hours after the call concludes and will be available through Tuesday, November 10, 2020, by dialing (844) 512-2921 from the U.S. and entering confirmation code 13711780, or (412) 317-6671 from international locations, and entering confirmation code 13711780.

There will also be a simultaneous, live webcast available on the Investor Relations section of the Company's web site at https://lifevantage.gcs-web.com/events-and-presentations or directly at http://public.viavid.com/index.php?id=141906. The webcast will be archived for approximately 30 days.

About LifeVantage Corporation

LifeVantage Corporation (Nasdaq: LFVN) is a pioneer in Nutrigenomics - a new science dedicated to biohacking the human aging code. The Company engages in the identification, research, development and distribution of advanced nutraceutical dietary supplements and skin and hair care products, including its Protandim® product line, LifeVantage® Omega+ and ProBio dietary supplements, the TrueScience® line of Nrf2 infused skin care and hair care products, Petandim® for Dogs, Axio® smart energy drink mixes, and the PhysIQ™ weight management system. LifeVantage was founded in 2003 and is headquartered in Salt Lake City, Utah. For more information, visit www.lifevantage.com.

Investor Relations Contact:

Scott Van Winkle
Managing Director, ICR
(617) 956-6736
scott.vanwinkle@icrinc.com 

Primary Logo


© GlobeNewswire 2020
All news about LIFEVANTAGE CORPORATION
11/17LIFEVANTAGE CORP : Change in Directors or Principal Officers, Submission of Matt..
AQ
11/03LIFEVANTAGE : Fiscal 1Q Earnings Snapshot
AQ
11/03LIFEVANTAGE CORP : Results of Operations and Financial Condition (form 8-K)
AQ
11/03LIFEVANTAGE : Announces Financial Results for the First Quarter of Fiscal 2021
AQ
11/03LifeVantage Announces Financial Results for the First Quarter of Fiscal 2021
GL
10/20LIFEVANTAGE : to Announce First Quarter Fiscal Year 2021 Results on November 3, ..
AQ
10/20LifeVantage to Announce First Quarter Fiscal Year 2021 Results on November 3,..
GL
09/08LIFEVANTAGE CORP : Change in Directors or Principal Officers (form 8-K)
AQ
09/08LIFEVANTAGE : Announces Management Transition
AQ
09/08LifeVantage Announces Management Transition
GL
More news
Financials (USD)
Sales 2020 233 M - -
Net income 2020 11,5 M - -
Net cash 2020 21,0 M - -
P/E ratio 2020 17,1x
Yield 2020 -
Capitalization 162 M 162 M -
EV / Sales 2019 0,75x
EV / Sales 2020 0,74x
Nbr of Employees -
Free-Float 91,7%
Chart LIFEVANTAGE CORPORATION
Duration : Period :
LifeVantage Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends LIFEVANTAGE CORPORATION
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Managers
NameTitle
Steven R. Fife President, Chief Executive & Financial Officer
Garry M. Mauro Chairman
Charles J. Wach Chief Operating Officer
Brian Dixon Senior Vice President-Research & Development
Michael A. Beindorff Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
LIFEVANTAGE CORPORATION-28.51%159
JOHNSON & JOHNSON-1.50%378 244
ROCHE HOLDING AG-3.47%285 939
NOVARTIS AG-11.58%203 854
PFIZER INC.-1.59%203 048
MERCK & CO., INC.-11.97%202 555